Swiss longevity biotech company Timeline (parent company Amazentis) announced that it has raised CHF 56 million (US$ 66 million) in an oversubscribed Series D financing round that included strategic investments by L’Oréal and Nestlé.
A pharmacokinetics study published in the Journal of Pharmaceutical and Biomedical Analysis provides a closer look at how potent phenolic compounds in a standardized pomegranate extract are metabolized by gut microbiota to confer health benefits.